Citric Acid

Citric Acid

SCHEMBL3160820

O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[C+4].[C+4].[C+4]

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BHRH2IMPA1

The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CA4 P22748 3/20 0.89
▸ ALDH1A1 P00352 1/20 0.33
▸ CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citric Acid SCHEMBL28661472 1.00 CA4 (0.89) CA4ALDH1A1CASP1
Citric Acid SCHEMBL773862 1.00 CA4 (0.89) CA4ALDH1A1CASP1
Citric Acid SCHEMBL28633158 0.97 CA4 (0.84) CA4ALDH1A1CASP1
Citric Acid SCHEMBL32659665 0.97 CA4 (0.84) CA4ALDH1A1CASP1
Citric Acid SCHEMBL28476620 0.97 CA4 (0.84) CA4ALDH1A1CASP1
Citric Acid SCHEMBL25311384 0.97 CA4 (0.84) CA4ALDH1A1CASP1
Citric Acid SCHEMBL22686437 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL29587574 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL1291555 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL42945 0.97 CA4 (0.94) CA4ALDH1A1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116376642-B Environment-friendly nano insulator cleaning agent and preparation method thereof 北京中铁科新材料技术有限公司 2024-03-22 — — CN claimed
CN-116376642-A Environment-friendly nano insulator cleaning agent and preparation method thereof 北京中铁科新材料技术有限公司 2023-07-04 — — CN claimed
CN-114686216-A Double-function nano lubricating additive and preparation method thereof 南京理工大学 2022-07-01 — — CN claimed
CN-114591723-A Aminated lignin citric acid composite quantum dot As3+Preparation method and application of fluorescent probe 陕西科技大学 2022-06-07 — — CN claimed
CN-111234818-B Method for synthesizing surface functional group modified carbon quantum dots and application of carbon quantum dots in nano oil displacement 西南石油大学 2022-03-18 — — CN claimed
CN-122010096-A Carbon dot corrosion inhibitor with excellent corrosion inhibition and tracing performance, preparation method and application 中国石油大学(华东) 2026-05-12 — — CN disclosed
US-12453480-B2 Systems and methods for assessing and treating hemorrhage and other conditions REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2025-10-28 — — US disclosed
US-20250290078-A1 HMO PRODUCING MICROORGANISM WITH INCREASED ROBUSTNESS TOWARDS GLUCOSE GRADIENTS DSM IP ASSETS B.V. (NL) 2025-09-18 — — US disclosed
US-20250108021-A1 METHOD FOR ENHANCING ENERGY PRODUCTION AND METABOLISM IN CELLS REPLICON HEALTH OY (FI) 2025-04-03 — — US disclosed
EP-4514989-A1 HMO PRODUCING MICROORGANISM WITH INCREASED ROBUSTNESS TOWARDS GLUCOSE GRADIENTS DSM IP Assets B.V. (NL) 2025-03-05 — — EP disclosed
CN-119350654-A Preparation method of carbon dot-based super-strong hydrogel 西南林业大学 2025-01-24 — — CN disclosed
US-12083084-B2 Method for enhancing energy production and metabolism in cells REPLICON HEALTH OY (FI) 2024-09-10 — — US disclosed
CN-105836774-A A rapid low-energy-consumption preparing method for tricalcium aluminate 武汉大学 2016-08-10 — — CN disclosed
US-20160033533-A1 2-HYDROXYGLUTARATE AS A BIOMARKER FOR CHRONIC HYPOXIA SLOAN KETTERING INST CANCER (US) 2016-02-04 — — US disclosed
CN-104803471-A Excellent and efficient carbon fiber biofilm carrier modification method CHANGZHOU ADVANCED MAT INST OF BEIJING UNIV CHEMIC 2015-07-29 — — CN disclosed
US-20140314728-A1 2-HYDROXYGLUTARATE AS A BIOMARKER FOR CHRONIC HYPOXIA NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2014-10-23 — — US disclosed
EP-2780700-A1 2-HYDROXYGLUTARATE AS A BIOMARKER FOR CHRONIC HYPOXIA Memorial Sloan Kettering Cancer Center (US) 2014-09-24 — — EP disclosed
WO-2013075065-A1 2-HYDROXYGLUTARATE AS A BIOMARKER FOR CHRONIC HYPOXIA MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2013-05-23 — — WO disclosed
EP-2156205-A1 SAMPLE PREPARATION METHOD FOR ENHANCEMENT OF NMR SENSITIVITY Oxford Instruments Molecular Biotools Limited (GB) 2010-02-24 — — EP disclosed
WO-2008149118-A1 SAMPLE PREPARATION METHOD FOR ENHANCEMENT OF NMR SENSITIVITY OXFORD INSTRUMENTS MOLECULAR BIOTOOLS LIMITED (GB) 2008-12-11 — — WO disclosed
Send feedback